ehaweb.org
EHA15 Jean Bernard Lifetime Achievement Award
EHA Library, Robin Foa, 5254
The delivery of healthcare in outreach countries
EHA Library, Ian Magrath, 4940
EHA15 José Carreras Lecture: Introduction
EHA Library, Ulrich Jäger, 4938
EHA15 Presentation EHA-José Carreras Young Investigator Fellowship & EHA Fellowships
EHA Library, Clara Camaschella, 4937
EHA15 Opening Ceremony : President's Speech
EHA Library, Jesús San Miguel, 4936
EHA15 Opening Ceremony: President's Speech
EHA Library, Robin Foa, 4935
Treatment of CML
EHA Library, Stephen O'Brien, 5248
Treatment of disease complications and unusual forms of myeloma
EHA Library, Michel Delforge, 4907
Management of MDS
EHA Library, Pierre Fenaux, 4910
Clinical trials in transfusion medicine
EHA Library, Aleksandar Mijovic, 4934
Type 3 von Willebrand disease
EHA Library, Frank Leebeek, 4893
PET-network for clinical trials
EHA Library, Michel Meignan, 4916
First-line treatment in peripheral T-cell lymphomas
EHA Library, F D'Amore, 4928
Role of SCT in management of AML
EHA Library, Jan Cornelissen, 4922
Treatment in PH-adult ALL
EHA Library, Oliver Ottmann, 4884
MRD oriented treatment in PH-adult ALL
EHA Library, Josep-Maria Ribera, 4883
Role of SCT in management of Myeloma
EHA Library, Jean-Luc Harousseau, 4921
Factor XI deficiency
EHA Library, Uri Seligsohn, 4892
Human platelet alloantibodies
EHA Library, Sentot Santoso, 4933
Epigenetic treatment strategies in MDS
EHA Library, Michael Lübbert, 4909
Risk adapted treatment
EHA Library, Keith Stewart, 4906
Molecular design of targeted therapy in Chronic Myelogenous Leukemia
EHA Library, François-Xavier Mahon, 4898
Pathology and pathogenesis of T-cell lymphoma
EHA Library, Philippe Gaulard, 4926
Role of oncogenic mutations and fusion genes in ALL
EHA Library, Jan Cools, 4882
European registry
EHA Library, Flora Peyvandi, 4891
PET in pediatric lymphoma
EHA Library, Martin Hutchings, 4914
Impact of myeloma biology in disease outcome
EHA Library, Hervé Avet-Loiseau, 4905
Molecular basis of CML
EHA Library, Junia Melo, 4897
PET for lymphoma management: Introduction
EHA Library, Lale Kostakoglu, 5253
Treatment of adult AML
EHA Library, Frederick Appelbaum, 4887
Treatment of extranodal DLBCL
EHA Library, Emmanuelle Zucca, 5247
GPVI shedding
EHA Library, Michael Berndt, 4890
Novel antibodies and immunomodulators for the therapy of CLL
EHA Library, Emili Montserrat, 4896
Lessons from the PT-1 study
EHA Library, Claire Harrison, 4913
Management of PNH
EHA Library, Anita Hill, 4919
Vaccination post-transplant
EHA Library, Per Ljungman, 4925
Novel therapies in AML
EHA Library, Alan Burnett, 4886
Coagulation as a target for cancer therapy
EHA Library, jerry Ware, 4930
Hypercoagulability in Sickle Cell Disease
EHA Library, John-John Schnog, 4903
Genetic markers of prognosis in CLL
EHA Library, Andrew Pettitt, 4895
Biological basis of PNH
EHA Library, Lucio Luzzatto, 4918
How to detect and measure microparticles
EHA Library, Paul Harrison, 4889
Targeting oncogenic pathways in DLBCL
EHA Library, Franck Morschhauser, 4900
Molecular pathogenesis of DLBCL
EHA Library, Georg Lenz, 4899
The role of antigenic stimulation in CLL Pathogenesis
EHA Library, Kostas Stamatopoulos, 4894
Biological functions and new developments of erythropoiesis-stimulating agents in management of anemia
EHA Library, Iain Macdougall, 4917
Management & diagnosis of CMV infection
EHA Library, Hermann Einsele, 4923
Molecular basis of AML
EHA Library, L Bullinger, 4885
The Platelet sheddome
EHA Library, Lawrence Brass, 4888
Lessons from congenital disorders of hematopoiesis
EHA Library, Karl Welte, 3456
Inflammation and thrombosis
EHA Library, Charles Esmon, 3457
Acute Myeloid Leukemia
EHA Library, Hartmut Döhner, 3695
Patterns of somatic mutation in human cancer genomes
EHA Library, Michael Stratton, 3458
Cost management in diagnosis and treatment of hematological disorders
EHA Library, Michael Rawlins, 3454
Dormancy in Stem Cells
EHA Library, Andreas Trumpp, 3459
High-throughput RNA interference screening identifies synthetic lethality between oncogenic KRAS dependency and suppression of STK33
EHA Library, Stefan Fröhling, 3583
Deletion of Dicer1 from Osteoprogenitor cells is sufficient to induce Myelodysplasia and hematopoietic Neoplasia
EHA Library, Marc Raaijmakers, 3584
A common constitutional JAK2 haplotype predisposes to Myeloproliferative neoplasms
EHA Library, Anthony Jones, 3585
Dose-intensified combined modality treatment with 2 cycles of beacopp escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABDV and IF-RT in patients with early unfavourable Hodgkin lymphoma (HL)…
EHA Library, Andreas Engert, 3586
EHA14 José Carreras Lecture: JAK2V617F Myeloproliferative disorders - A single or several genetic events
EHA Library, William Vainchenker, 3453
EHA14 Introduction of José Carreras winner
EHA Library, Robin Foa, 3698
Down and B ALL
EHA Library, Shai Izraeli, 3379
Transfusion in neonates and children
EHA Library, Naomi Luban, 3443
Thrombin or factor Xa: does the target matter?
EHA Library, Harry Büller, 3439
Current status of treatment with allogeneic SCT with reduced intensity conditioning
EHA Library, Alois Gratwohl, 3435
Risk adapted CLL management
EHA Library, Peter Hillmen, 3391
Do commonly used clinical trial designs reflect clinical reality?
EHA Library, Elihu Estey, 3399
Interferon in the treatment of MPD
EHA Library, Jean-Jacques Kiladjian, 3423
Treatment of MDS
EHA Library, Mario Cazzola, 3419
Genetic and epigenetic programs in MLL-rearranged ALL
EHA Library, Scott Armstrong, 3378
Transfusion problems in stem cell transplantation
EHA Library, Derwood Pamphilon, 3442
Bench to bedside in thrombosis
EHA Library, Trevor Baglin, 3438
Clinical implications of biological markers in CLL
EHA Library, Richard Rosenquist, 3390
Reduced intensity conditioning as a platform for immunotherapy
EHA Library, John Barrett, 3434
The use of genomics in today's clinical trial design: pitfalls in the statistical evaluation
EHA Library, Richard Simon, 3398
A risk stratification based approach to the treatment of primary Myelofibrosis
EHA Library, Ronald Hoffman, 3422
Dynamics of hematopoietic stem cell compartments
EHA Library, Markus MANZ, 3406
Pathogenesis and basic aspects of MDS
EHA Library, Azra Raza, 3417
Genetic Profiling in B ALL
EHA Library, Charles Mullighan, 3460
Pathogenesis of MPD
EHA Library, Robert Kralovics, 3421
Anatomy of the stem cell niche
EHA Library, Elaine Dzierzak, 3405
Designing and interpreting quality of life and other patient-reported outcomes in clinical trials
EHA Library, Fabio Efficace, 3397
Genetics of Thrombosis
EHA Library, Pieter Reitsma, 3437
The origin of CLL
EHA Library, Ulf Klein, 3389
Immunobiology of reduced intensity conditioning in SCT
EHA Library, Brenda Sandmaier, 3433
Treatment options for myeloma in 2009
EHA Library, Joan Bladé, 3415
Treatment options for relapsing patients
EHA Library, Christian Gisselbrecht, 3403
Pediatric MPD
EHA Library, Maria Luigia Randi, 3427
Diagnosis, treatment and management of Erythrocytosis
EHA Library, Mary Frances McMullin, 3431
Second generation TKIs: which and when?
EHA Library, H Kantarjian, 3395
Treatment options in von Willebrand Disease
EHA Library, Augusto Federici, 3387
Risk adapted treatment of AML
EHA Library, Jorge Sierra, 3383
Therapeutic strategies in hairy cell leukemia
EHA Library, Daniel Catovsky, 3447
Recent advances in the treatment of early stages of Hodgkin lymphoma
EHA Library, Andreas Engert, 3411
Experimental agents knocking at the door of Myeloma treatment
EHA Library, Nikhil Munshi, 3414
The role of PET in the management of Hodgkin's lymphoma
EHA Library, Andrea Gallamini, 3410
Developing new treatments for diffuse large B cell Lymphoma
EHA Library, Margaret Shipp, 3402
Dynamics of mutated clones
EHA Library, Andreas Hochhaus, 3394
Phenotype, Genotype and Classification in von Willebrand disease
EHA Library, Anne Goodeve, 3386
Minimal residual disease
EHA Library, Giuseppe Saglio, 3382

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings